🇺🇸 Rimegepant 75mg Orally Disintegrating Tablets (ODT) in United States

Rimegepant 75mg Orally Disintegrating Tablets (ODT) (rimegepant-75mg-orally-disintegrating-tablets-odt) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

Rimegepant 75mg Orally Disintegrating Tablets (ODT) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Rimegepant 75mg Orally Disintegrating Tablets (ODT) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rimegepant 75mg Orally Disintegrating Tablets (ODT) in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Rimegepant 75mg Orally Disintegrating Tablets (ODT) cost in United States?

annual_list: USD 7000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.